Comparative Effectiveness and Safety of Off-Label Underdosed Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis.
Pajaree MongkhonNoppaket SingkhamKunyarat PonokNatpatsorn LiamsrijanWipada PhoosaSirayut PhattanasobhonLaura FanningVichai SenthongSurasak SaokaewPublished in: Drug safety (2024)
Off-label underdosed DOACs, particularly rivaroxaban, was associated with increased ISSE risk but did not decrease bleeding compared to on-label. Adherence to appropriate DOAC doses should be emphasised to achieve the best clinical outcomes for Asian patients with AF.